Last reviewed · How we verify

Punctum Plug

Ocular Therapeutix, Inc. · Phase 3 active Small molecule

Punctum Plug is a biodegradable collagen shield used to treat punctal occlusion.

Punctum Plug is a biodegradable collagen shield used to treat punctal occlusion. Used for Treatment of dry eye disease.

At a glance

Generic namePunctum Plug
SponsorOcular Therapeutix, Inc.
ModalitySmall molecule
Therapeutic areaOphthalmology
PhasePhase 3

Mechanism of action

Punctum Plug works by physically blocking the tear ducts to reduce tear drainage and alleviate dry eye symptoms. This is achieved through the insertion of a biodegradable collagen shield into the tear duct, which gradually dissolves over time.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: